Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods

Clicks: 378
ID: 274271
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #18 of 329 articles by views in american journal of epidemiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 329 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The authors compared five methods of studying survival bias associated with time-to-treatment initiation in a drug effectiveness study using medical administrative databases (1996-2002) from Quebec, Canada. The first two methods illustrated how survival bias could be introduced. Three additional met …
Reference Key
z2005americansurvival Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zhou Z;Rahme E;Abrahamowicz M;Pilote L;;
Journal american journal of epidemiology
Year 2005
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/16192344
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Health Care humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male aged Drug Administration Schedule Comparative Study 80 and over Retrospective Studies Evaluation Study follow-up studies Cohort Studies Survival Analysis bias secondary prevention outcome and process assessment drug prescriptions / statistics & numerical data myocardial infarction / prevention & control quebec / epidemiology pmid:16192344 doi:10.1093/aje/kwi307 zheng zhou elham rahme louise pilote hydroxymethylglutaryl-coa reductase inhibitors / administration & dosage* myocardial infarction / drug therapy* myocardial infarction / mortality*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.